Recombinant extracellular vesicles
Engineering of CD81 on extracellular vesicles to target specific cell surface proteins. September 17, 2021, Vienna, Austria We have developed a
7
02, 2026
2
09, 2025
Fetal vs Perinatal EVs as potential OA Therapeutics
Fetal vs Perinatal EVs as potential OA Therapeutics September 2nd, 2025, Vienna, Austria We are pleased to share a new publication
27
05, 2025
P-MSC/TERT308 as model to optimize cellular cytotoxicity assays
P-MSC/TERT308 as model to optimize cellular cytotoxicity assay May 27th, 2025, Vienna, Austria We are pleased to share a new research note
15
05, 2025
Participation to TERMIS EU 2025
TERMIS EU 2025 May 15th, 2025, Vienna, Austria Our co-founder, COO/CSO Regina Grillari is a selected speaker at Termis EU Congress
8
05, 2025
Participation to Cell Culture Days 2025
Cell Culture Days 2025 May 8th, 2025, Vienna, Austria Our co-founder, COO/CSO Regina Grillari is an invited speaker at the Cell
16
04, 2025
Newly released telomerized trophoblasts
Newly released telomerized trophoblasts April 16th, 2025, Vienna, Austria We are thrilled to announce a newest addition to our cell portfolio:
8
04, 2025
Participation to ISEV 2025
Meet us at ISEV2025 April 8th, 2025, Vienna, Austria Visit us at booth B13 at the ISEV 2025 meeting in Vienna,
1
04, 2025
Newly released telomerized endometrium-derived MSC
Newly released telomerized endometrium-derived MSC April 1st, 2025, Vienna, Austria We are thrilled to announce the newest addition to our cell portfolio: Telomerized
14
03, 2025
3D imaging of RPTEC/TERT1 in microphysiological systems
3D imaging of RPTEC/TERT1 in microphysiological systems March 14th, 2025, Vienna, Austria We are pleased to share a new application note
10
03, 2025
New Cell Systems developed in collaboration with AIM Biotech
New Cell Systems developed in collaboration with AIM Biotech March 10th, 2025, Vienna, Austria Two innovative 3D assay kits for advanced